Fever Clinical Trials

68 recruitingLast updated: June 18, 2026

There are 68 actively recruiting fever clinical trials across 45 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1. Top locations include Paris, France, Bethesda, Maryland, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Fever Trials at a Glance

68 actively recruiting trials for fever are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Paris, Bethesda, and Baltimore. Lead sponsors running fever studies include Takeda, Cairo University, and Novartis Pharmaceuticals.

Browse fever trials by phase

Treatments under study

About Fever Clinical Trials

Looking for clinical trials for Fever? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fever trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fever clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 68 trials

Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Genetic diseasesFeverROSAH+4 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

Still DiseaseAdult Onset Still DiseaseFamilial Mediterranean Fever+1 more
Novartis Pharmaceuticals160 enrolled1 locationNCT07517250
Recruiting
Not Applicable

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Crimean-Congo Haemorrhagic Fever
Liverpool School of Tropical Medicine492 enrolled6 locationsNCT06624787
Recruiting

Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform

Skin DiseasesFeverHemorrhagic Fever With Renal Syndrome+3 more
OpenGenome1,000 enrolled1 locationNCT07578610
Recruiting

Ilaris NIS in Korea

Systemic Juvenile Idiopathic Arthritis (sJIA)Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)+3 more
Novartis Pharmaceuticals25 enrolled1 locationNCT06838143
Recruiting
Not Applicable

Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

TemperatureBlood PressureCardiac Arrest (CA)+9 more
Helsinki University Central Hospital3,500 enrolled52 locationsNCT07579390
Recruiting
Phase 3

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

Yellow Fever Immunization
Sanofi2,440 enrolled13 locationsNCT07103148
Recruiting
Phase 4

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Enteric Fever
Indus Hospital and Health Network40 enrolled1 locationNCT07314281
Recruiting
Phase 3

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

Dengue Fever
Takeda800 enrolled7 locationsNCT06579755
Recruiting

Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

Children Under 3 Months of Age With Fever
Assistance Publique - Hôpitaux de Paris180 enrolled2 locationsNCT06618989
Recruiting
Phase 2Phase 3

The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.

Axial Spondylarthritis (axSpA)IgG4-related DiseaseInflammation of Unknown Origin+1 more
Universitaire Ziekenhuizen KU Leuven140 enrolled1 locationNCT07535554
Recruiting

A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue

Dengue Fever
Takeda70,000 enrolled7 locationsNCT06843226
Recruiting

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Obstructive Sleep ApneaSleep-Disordered BreathingTonsillitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID)1,500 enrolled3 locationsNCT05656365
Recruiting
Phase 4

Safety of RSV Preventive Monoclonal Antibody

FeverAdverse Event Following Immunisation
Duke University524 enrolled6 locationsNCT07158814
Recruiting
Phase 2

ARN-75039 Lassa Fever Treatment in West Africa

Lassa Fever
Arisan Therapeutics, Inc.135 enrolled4 locationsNCT07419373
Recruiting
Not Applicable

Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts

HypertensionBreathlessnessDiabete Mellitus+1 more
Sarah Nabia672 enrolled1 locationNCT07432893
Recruiting

International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)

Dengue FeverDengue DiseaseDengue Haemorrhagic Fever+1 more
Mahidol University100 enrolled1 locationNCT07409857
Recruiting
Phase 2Phase 3

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

Lassa Fever
Irrua Specialist Teaching Hospital1,755 enrolled4 locationsNCT06212336
Recruiting

Continuos Body Temperature Monitoring

Fever
Baby FM Doo40 enrolled1 locationNCT06447337
Recruiting

Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

Familial Mediterranean Fever (FMF)
Tongji Hospital12 enrolled1 locationNCT07077473